Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Polymorphisms in NQO1, IL-10 and PTPN11, in combination with HP status, could be used to identify individuals who are more likely to develop IM and therefore GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP708359.RAh_7MnhuatHh7qY81m0lmW0aO6EpqIa_-qAMGMwfG63E130_assertion description "[Polymorphisms in NQO1, IL-10 and PTPN11, in combination with HP status, could be used to identify individuals who are more likely to develop IM and therefore GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP708359.RAh_7MnhuatHh7qY81m0lmW0aO6EpqIa_-qAMGMwfG63E130_provenance.
• NP539482.RAxosQE8Ia1efd01IohB6Usz74citMcnDndEDPD_fAjUw130_assertion description "[Polymorphisms in NQO1, IL-10 and PTPN11, in combination with HP status, could be used to identify individuals who are more likely to develop IM and therefore GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP539482.RAxosQE8Ia1efd01IohB6Usz74citMcnDndEDPD_fAjUw130_provenance.
• NP446610.RALSkcTxkxt87GFUcI46876Ma93yuj-58GmGmCBG1JKYc130_assertion description "[Polymorphisms in NQO1, IL-10 and PTPN11, in combination with HP status, could be used to identify individuals who are more likely to develop IM and therefore GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP446610.RALSkcTxkxt87GFUcI46876Ma93yuj-58GmGmCBG1JKYc130_provenance.
• NP329579.RAI1vQf_Twp-CmqWjOtw3FdB57cg1aKzh2dS9lsKqR3cA130_assertion description "[Polymorphisms in NQO1, IL-10 and PTPN11, in combination with HP status, could be used to identify individuals who are more likely to develop IM and therefore GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP329579.RAI1vQf_Twp-CmqWjOtw3FdB57cg1aKzh2dS9lsKqR3cA130_provenance.
• NP354192.RAcUubWo_3aTBEZDrdNzuSJQ6DUwzSSqMx-6e3LpdH-GQ130_assertion description "[Polymorphisms in NQO1, IL-10 and PTPN11, in combination with HP status, could be used to identify individuals who are more likely to develop IM and therefore GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP354192.RAcUubWo_3aTBEZDrdNzuSJQ6DUwzSSqMx-6e3LpdH-GQ130_provenance.
• NP768883.RACfitbHzA9Rh3H40-8VUsH8J-M4bti9K0vdK6VJbK7NI130_assertion description "[Polymorphisms in NQO1, IL-10 and PTPN11, in combination with HP status, could be used to identify individuals who are more likely to develop IM and therefore GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP768883.RACfitbHzA9Rh3H40-8VUsH8J-M4bti9K0vdK6VJbK7NI130_provenance.
• NP768878.RARFRI-rSLKNFneAbA7-B9SjJ_1IgFEJUhbz8V3b0C2D4130_assertion description "[Polymorphisms in NQO1, IL-10 and PTPN11, in combination with HP status, could be used to identify individuals who are more likely to develop IM and therefore GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP768878.RARFRI-rSLKNFneAbA7-B9SjJ_1IgFEJUhbz8V3b0C2D4130_provenance.
• NP768881.RAaUv4xi3Yn59xKdQuAY4iHlpvKr7Nf7QMrEkSIv1vZTg130_assertion description "[Polymorphisms in NQO1, IL-10 and PTPN11, in combination with HP status, could be used to identify individuals who are more likely to develop IM and therefore GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP768881.RAaUv4xi3Yn59xKdQuAY4iHlpvKr7Nf7QMrEkSIv1vZTg130_provenance.
• NP353977.RArTOHBqDJOdFgF5ZUHEMlghxXGBGuqzw9GEO2qsJ8B4k130_assertion description "[Polymorphisms in NQO1, IL-10 and PTPN11, in combination with HP status, could be used to identify individuals who are more likely to develop IM and therefore GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP353977.RArTOHBqDJOdFgF5ZUHEMlghxXGBGuqzw9GEO2qsJ8B4k130_provenance.
• NP660679.RArZPx4DeUFyuWNy0vgAFlPb6p09xL3AbVoDC0vTM29DQ130_assertion description "[Polymorphisms in NQO1, IL-10 and PTPN11, in combination with HP status, could be used to identify individuals who are more likely to develop IM and therefore GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660679.RArZPx4DeUFyuWNy0vgAFlPb6p09xL3AbVoDC0vTM29DQ130_provenance.
• NP768879.RAilwxe0LJSIHjV1HOed26AuISPMFpN2kBrZHzZSDcPsU130_assertion description "[Polymorphisms in NQO1, IL-10 and PTPN11, in combination with HP status, could be used to identify individuals who are more likely to develop IM and therefore GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP768879.RAilwxe0LJSIHjV1HOed26AuISPMFpN2kBrZHzZSDcPsU130_provenance.
• NP660464.RA9xwAtrwC4gmoKiubsLzjBQRrywpdkZD0PbUqnWJbzYs130_assertion description "[Polymorphisms in NQO1, IL-10 and PTPN11, in combination with HP status, could be used to identify individuals who are more likely to develop IM and therefore GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660464.RA9xwAtrwC4gmoKiubsLzjBQRrywpdkZD0PbUqnWJbzYs130_provenance.
• NP768877.RA7cHnRYwDLYK3jlhk3bnZK7EavvMQuFztYIw3VcJqdsE130_assertion description "[Polymorphisms in NQO1, IL-10 and PTPN11, in combination with HP status, could be used to identify individuals who are more likely to develop IM and therefore GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP768877.RA7cHnRYwDLYK3jlhk3bnZK7EavvMQuFztYIw3VcJqdsE130_provenance.
• NP768882.RA1W4VtmKW4bvaNfkP22zQ3kxVcsFFGvkqAcvZZCZOJBQ130_assertion description "[Polymorphisms in NQO1, IL-10 and PTPN11, in combination with HP status, could be used to identify individuals who are more likely to develop IM and therefore GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP768882.RA1W4VtmKW4bvaNfkP22zQ3kxVcsFFGvkqAcvZZCZOJBQ130_provenance.